Kestra Medical Technologies, Ltd.
KMTS
$24.83
-$0.38-1.51%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.96% | -29.88% | -133.59% | 0.51% | 18.88% |
| Total Depreciation and Amortization | 26.97% | -14.61% | -47.57% | -43.86% | -20.38% |
| Total Amortization of Deferred Charges | -29.20% | 134.50% | 84.50% | -13.71% | 520.66% |
| Total Other Non-Cash Items | 354.51% | 142.69% | 1,972.01% | 19.95% | 32.71% |
| Change in Net Operating Assets | 127.20% | -315.06% | -256.92% | -91.67% | -2,625.60% |
| Cash from Operations | -1.59% | -50.15% | -58.54% | -16.38% | 12.96% |
| Capital Expenditure | -62.20% | -17.17% | -91.48% | 18.22% | -176.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.78% | 60.87% | 573.81% | -- | 70.00% |
| Cash from Investing | -67.87% | -17.03% | -86.61% | 18.17% | -184.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.30% | -114.59% | -1,210.61% | 80.27% | 49.67% |
| Cash from Financing | 95.30% | -101.61% | 1,654.68% | -101.00% | -102.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.88% | -139.67% | 2,766.90% | -154.58% | -612.47% |